Jennifer Balliet's most recent trade in Neogenomics Inc. was a trade of 21,400 Common Stock done . Disclosure was reported to the exchange on Dec. 30, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neogenomics Inc. | Jennifer Balliet | VP and Chief Culture Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2021 | 21,400 | 48,615 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Jennifer Balliet | VP and Chief Culture Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2021 | 4,050 | 4,050 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Jennifer Balliet | VP and Chief Culture Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2021 | 758 | 27,215 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Jennifer Balliet | VP and Chief Culture Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 10,551 | 10,551 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Jennifer Balliet | VP and Chief Culture Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 1,862 | 26,457 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Jennifer Balliet | VP and Chief Culture Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2021 | 212 | 24,768 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Jennifer Balliet | VP and Chief Culture Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Mar 2021 | 173 | 24,595 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Jennifer Balliet | VP and Chief Culture Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.03 per share. | 11 Dec 2020 | 15,000 | 39,980 (0%) | 0% | 8.0 | 120,450 | Common Stock |
| Neogenomics Inc. | Jennifer Balliet | VP and Chief Culture Officer | Sale of securities on an exchange or to another person at price $ 49.99 per share. | 11 Dec 2020 | 15,000 | 24,980 (0%) | 0% | 50.0 | 749,850 | Common Stock |
| Neogenomics Inc. | Jennifer Balliet | VP and Chief Culture Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2020 | 15,000 | 33,334 | - | - | Stock Option (Right to Buy) |